Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 89

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 14
Chunk 89
---

    10.1

    10.19#
     
    Amendment No. 4 to the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan

    X

F-31

    10.20#
     
    Form of restricted stock unit agreement under Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan
     
    10-K

    3/30/2022

    10.17

    10.21#
     
    Crinetics Pharmaceuticals, Inc. Excess Deferral Plan Adoption Agreement 
     
    10-Q

    5/9/2024

    10.1

    10.22#
     
    Amended and Restated Employment Agreement, effective as of May 22, 2018, by and between Stephen Betz and the Registrant 
     
    10-K

    3/30/2022

    10.18

    10.23#
     
    Employment Agreement, effective as of September 13, 2021, by and between Jeff Knight and the Registrant
     
    10-K

    3/30/2022

    10.19

    10.24#
     
    Consulting Agreement, effective as of October 15, 2024, between Crinetics Pharmaceuticals, Inc. and James Hassard 
     
    8-K

    10/16/2024

    10.1

    10.25#
     
    Separation and Release Agreement, dated October 10, 2024, between Crinetics Pharmaceuticals, Inc. and James Hassard. 
     
    8-K

    10/16/2024

    10.2

    10.26#
     
    Employment Agreement, effective as of September 30, 2022, by and between Dana Pizzuti and the Registrant
     
    10-Q

    11/14/2022

    10.2

    10.27#
     
    Employment Agreement, effective December 16, 2024, by and between Isabel Kalofonos and the Registrant

    X

    10.28#
     
    Sales Agreement, dated June 21, 2024, by and among Crinetics Pharmaceuticals, Inc